Apollo Cancer Centres Launches ‘End-O Check’ – An Early Screening and Diagnosis Program for Endometrial and Ovarian Cancers


End-O Check will provide risk-based assessments, diagnostic testing, and symptom evaluation for women, particularly those in the postmenopausal age group.

Thank you for reading this post, don't forget to subscribe!

Kolkata, July 30, 2025: Reinforcing its commitment to preventive oncology for women, Apollo Cancer Centres (ACCs) today launched End-O Check, a comprehensive early detection program targeting women aged 45 and above. The initiative is designed to detect two of the most prevalent gynaecologic cancers—endometrial and ovarian—at an early and more treatable stage. While endometrial cancer often presents with symptoms such as unexpected bleeding or abnormal discharge, many women fail to report these signs early, leading to delayed diagnosis and poorer outcomes. End-O Check is designed with a focus on early detection in high-risk populations, symptom awareness, and timely intervention, empowering women to take proactive steps for their gynaecologic health.

Speaking at the launch, Mr. Dinesh Madhavan, President, Group Oncology & International, Apollo Hospitals Enterprise Ltd, said, “Early detection remains our most powerful ally in improving survival and quality of life in cancer care. End O Check is a proactive step in shifting the narrative from treatment to screening and early diagnosis, enabling timely detection, and precision treatment by cancer management teams “.

Dr Subrato R Debnath, Senior Consultant – Gynae Oncology and Robotic Surgeon, Apollo Cancer Centre, Kolkata, said, “Endometrial cancer has been on the rise in women above the age of 45 years, so early detection is crucial for better outcomes. Global data indicate a five-year survival rate of around 96% for localised disease. However, survival rates drop substantially when diagnosis is delayed, underscoring the importance of timely detection. Key risk factors include obesity, diabetes, early menstruation, late menopause, and polycystic ovary syndrome (PCOS), all of which are becoming more prevalent among Indian women.”

Dr. Surinder Singh Bhatia – Director Medical Services, Eastern Region Apollo Cancer Centre, added, “With End O Check, we are expanding our preventive oncology efforts. This program is about creating sustained awareness, encouraging women to prioritise their health, and ensuring equitable access to reliable cancer detection tools. Early detection not only saves lives—it also enables less invasive, more effective treatment options.”

 #WinningOverCancer

About Apollo Cancer Centre – https://apollocancercentres.com/

THE CANCER CARE LEGACY: BREATHING HOPE INTO LIVES FOR OVER 30 YEARS

Cancer care today means comprehensive care that encompasses all aspects, which requires commitment, expertise, and an indomitable spirit from cancer specialists.  Apollo Cancer Centre has a network spread across India with over 400 oncologists to oversee the delivery of high-end precision Oncology Therapy. Our oncologists deliver world-class cancer care through an organ-based practice, supported by competent Cancer Management Teams. This helps us in delivering exemplary treatment to the patient in an environment that has consistently delivered an international standard of clinical outcomes.  Today, people from 147 countries come to India for cancer treatment at Apollo Cancer Centres. With the first Pencil Beam Proton Therapy Centre in South Asia & the Middle East, Apollo Cancer Centre has all that is needed to strengthen the battle against cancer. All domestic and international patients can contact us through our dedicated patient Helpline number: 04048964515. We are available 24×7.

About The Author


Verified by MonsterInsights